Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Agilent; Fluidigm, Sygnis; and More

NEW YORK (GenomeWeb) – Agilent this week announced it has completed the asset acquisition of iLab Solutions. Agilent first announced its intention to acquire the laboratory management software firm's assets at the end of June, and now owns iLab's technology, intellectual property, and product portfolio. iLab's employees will now be a part of Agilent CrossLab Group's Laboratory Enterprise Division.

Fluidigm said this week that it has received ISO 13485:2003 and ISO 9001:2008 certification for the design, development, manufacturing, and distribution of single-cell genomics and high-throughput genomics systems. The company's certified San Francisco facility designs and develops instrumentation, integrated fluidic circuits (IFCs), reagents, and software, and manufactures high-performance genomic reagents and conjugated antibodies. Its certified Singapore facility manufactures Fluidigm instruments IFCs for analysis of single cells and nucleic acids from blood, tissues, and tumor samples.

Sygnis reported its half-year earnings this week. The company's revenues for the first half of the year rose 63 percent to €319,000 from €196,000 for the same period in 2015 thanks to an increase in kit sales. The company's net loss narrowed by €464,000, mainly because of higher revenues, lower operating expenses, and lower interest expenses. Sygnis' cash and cash equivalents at the end of June totaled €2.4 million.

Rosetta Genomics announced this week that it has signed a new participation agreement with preferred provider organization Galaxy Health Network as a preferred laboratory provider.

PreventionGenetics said this week it has received ISO 15189:2012 accreditation through the American Association for Laboratory Accreditation, making it a provider of choice for international companies seeking next-gen panels, single-gene tests, and deletion/duplication testing via high-density gene-centric aCGH.

Gene synthesis services provider GenScript USA this week announced the winners of its CRISPR/Cas9 grants for this year's Internationally Genetically Engineered Machine (iGEM) competition. Teams from the Alverno High School, Blue Valley Center for Advanced Professional Studies, Boston University, College of William and Mary, Duke University, Eindhoven University of Technology, EPFL Switzerland, ETH Zurich University, Linköping University, Northwestern University, Texas Tech University, Tsinghua University, Tufts University, University of Warwick, UCC Ireland, and Worcester Polytechnic Institute will receive grants of up to $5,000 to use as they like in preparing their iGEM projects.

Integrated DNA Technologies said this week that it plans to donate reagents to Eliminate Dengue Brazil to help combat the spread of Zika virus in Brazil. The Eliminate Dengue Program is an international, non-profit research collaboration led by Monash University professor Scott O'Neill. The team is developing a natural method for controlling mosquito-transmitted diseases, including dengue, Zika, and chikungunya. The Brazil project team is infecting mosquitoes with Wolbachia bacteria to reduce the mosquito's ability to transmit the virus to humans. The researchers are using IDT's Zen Double-Quenched Probes to monitor the persistence of viruses within the mosquito population.

In Brief This Week is a selection of news items that may be of interest to our readers but had not previously appeared on the GenomeWeb site.